SiteOne Therapeutics
Yizhao Li currently serves as the Director of Development Operations at SiteOne Therapeutics, Inc., starting in May 2024. Prior to this role, Yizhao held positions at Terns Pharmaceuticals, including Associate Director and Sr. Clinical Program Manager from March 2021 to May 2024. Yizhao's extensive experience at Gilead Sciences spanned from September 2014 to March 2021, where Yizhao advanced from Clinical Trial Management Associate to Sr. Clinical Trials Manager. Earlier experience includes the role of Clinical Project Coordinator at Baxter International Inc. and various positions at PAREXEL. Yizhao Li earned a Bachelor's of Science in Human Biology from the University of California, San Diego.
This person is not in any teams
SiteOne Therapeutics
SiteOne Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of hypersensitivity disorders such as chronic cough, itch, and pain.